Cardiac biosensors represent a cutting-edge technology in the field of healthcare and diagnostics, offering innovative solutions for monitoring and assessing cardiovascular health. These biosensors leverage advanced sensing technologies to detect specific biomarkers or physiological signals associated with cardiac conditions. By providing real-time and accurate data, cardiac biosensors empower healthcare professionals to make timely and informed decisions, leading to more personalized and effective patient care. These devices play a pivotal role in early detection, continuous monitoring, and management of cardiovascular diseases, contributing to improved patient outcomes. As research and development in the realm of biosensing technologies continue to advance, the integration of cardiac biosensors holds great promise for enhancing the precision and efficiency of cardiovascular healthcare, paving the way for a future where proactive and personalized cardiac monitoring becomes a standard in patient care.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India